Work

Investigations into the Mechanisms and Clinical Implications of Modulation of Hepcidin Levels By Luspatercept in TD MDS and TD b-Thalassemia

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-166559

Authors: Aarif Ahsan, Wei Fang, Manuel Ugidos, Danny V Jeyaraju, Pierre Fenaux, Uwe Platzbecker, Olivier Hermine, John B. Porter, Rajasekhar N.V.S. Suragani, Sadanand Vodala, Anita K. Gandhi

Institutions: Bristol-Myers Squibb (United States), Université Paris Cité, Hôpital Saint-Louis, University Hospital Leipzig, Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris, University College London

Language: English

Topic: Iron Metabolism and Disorders

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310113812

FWCI: 0.538

Cites:

Cited by: 3

Related to: 10